NeoGenomics Ownership | Who Owns NeoGenomics?

Overview Forecast RevenueFinancials Chart Transcripts

NeoGenomics Ownership Summary

NeoGenomics is owned by 516.32% institutional investors, 1.93% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 77.57% of NEO shares. First Trust NYSE Arca Biotech ETF is the top mutual fund, with 7.51% of its assets in NeoGenomics shares.

NEO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	NeoGenomics	516.32%	1.93%	-418.25%
Sector	Healthcare Stocks	35.38%	11.35%	53.27%
Industry	Diagnostics & Research Stocks	50.85%	10.56%	38.59%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	19.96M	77.57%	$148.08M
Vanguard group	13.83M	54.05%	$162.62M
First light asset management	9.73M	37.82%	$72.20M
Greenhouse funds lllp	9.10M	35.37%	$67.52M
First trust advisors lp	6.16M	23.95%	$45.72M
Braidwell lp	5.62M	21.83%	$41.68M
State street	5.12M	19.90%	$37.99M
Deerfield management company, l.p. (series c)	4.45M	17.38%	$34.33M
D. e. shaw	4.16M	16.18%	$30.90M
Blackrock	19.67M	15.56%	$272.82M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
First light asset management	9.73M	6.47%	$72.20M
Greenhouse funds lllp	9.10M	3.02%	$67.52M
Highmark wealth management	579.83K	1.75%	$4.30M
Braidwell lp	5.62M	1.39%	$41.68M
Pfm health sciences, lp	1.78M	1.21%	$13.24M
Bullseye asset management	236.86K	1.02%	$1.76M
Samjo management	316.67K	1.02%	$2.35M
Perkins capital management	132.35K	0.92%	$982.04K
American capital management	2.25M	0.90%	$16.70M
Bryce point capital	64.08K	0.60%	$494.73K

Top Buyers

Holder	Shares	% Assets	Change
First trust advisors lp	6.16M	0.03%	6.16M
Deerfield management company, l.p. (series c)	4.45M	0.52%	2.30M
Samlyn capital	2.56M	0.32%	1.17M
Braidwell lp	5.62M	1.39%	984.60K
Vanguard fiduciary trust	847.30K	0.00%	847.30K

Top Sellers

Holder	Shares	% Assets	Change
Millennium management	2.22M	0.01%	-2.98M
Macquarie group	-	-	-2.54M
T. rowe price investment management	-	-	-2.22M
Jennison associates	-	-	-1.66M
D. e. shaw	4.16M	0.02%	-1.13M

New Positions

Holder	Shares	% Assets	Change	Value
First trust advisors lp	6.16M	0.03%	6.16M	$45.72M
Vanguard fiduciary trust	847.30K	0.00%	847.30K	$6.29M
Granite investment partners	752.48K	0.34%	752.48K	$5.58M
Fred alger management	651.65K	0.02%	651.65K	$4.84M
Norges bank	380.66K	0.00%	380.66K	$6.27M

Sold Out

Holder	Change
Dinuzzo private wealth	-1.00
Bay harbor wealth management	-1.00
Capital performance advisors llp	-2.00
Elequin securities	-6.00
Claris advisors, llc / mo /	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	258	-1.90%	132,846,742	1.55%	516	0.20%	117	-0.85%	85	-4.49%
Dec 31, 2025	168	-35.63%	64,898,894	-49.63%	253	0.10%	74	-37.82%	56	-35.63%
Sep 30, 2025	245	-10.58%	128,465,467	5.96%	502	5.59%	117	-22.52%	83	25.76%
Jun 30, 2025	278	5.70%	127,009,885	0.72%	99	1.01%	154	35.09%	67	-25.56%
Mar 31, 2025	8	-96.91%	13,898,618	-88.67%	10	0.12%	5	-94.95%	2	-97.94%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
First Trust NYSE Arca Biotech ETF	9.78M	7.51%	-45.62K
iShares Core S&P Small-Cap ETF	7.89M	6.06%	1.99K
Vanguard Total Stock Mkt Idx Inv	4.07M	3.13%	-
Vanguard US Total Market Shares ETF	3.99M	3.11%	4.14K
Macquarie Small Cap Core I	3.61M	2.79%	-271.16K
Delaware Small Cap Core I	3.12M	2.44%	478.93K
iShares Russell 2000 ETF	3.03M	2.33%	25.57K
Vanguard Small Cap Index	3.00M	2.30%	62.17K
American Century U.S. Small Cap Growth	2.75M	2.14%	150.02K
American Century Small Cap Growth Inv	2.75M	2.14%	150.02K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 20, 2026	Stone Warren	Pres & Chief Operating Officer	Sell	$276.68K
Nov 25, 2025	Olivo Alicia C	EVP, GC & Business Development	Sell	$250.99K
Aug 06, 2025	Sherman Jeffrey Scott	Chief Financial Officer	Buy	$112.32K
Aug 06, 2025	Zook Anthony P.	Chief Executive Officer	Buy	$99.95K
May 27, 2025	Kelly Michael Aaron	-	Buy	$38.00K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	1
2025 Q4	-	1
2025 Q3	2	-
2025 Q2	8	-

NEO Ownership FAQ

Who Owns NeoGenomics?

NeoGenomics shareholders are primarily institutional investors at 516.32%, followed by 1.93% insiders and -418.25% retail investors. The average institutional ownership in NeoGenomics's industry, Diagnostics & Research Stocks, is 50.85%, which NeoGenomics exceeds.

Who owns the most shares of NeoGenomics?

NeoGenomics’s largest shareholders are Blackrock funding, inc. /de (19.96M shares, 77.57%), Vanguard group (13.83M shares, 54.05%), and First light asset management (9.73M shares, 37.82%). Together, they hold 169.43% of NeoGenomics’s total shares outstanding.

Does Blackrock own NeoGenomics?

Yes, BlackRock owns 15.56% of NeoGenomics, totaling 19.67M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 272.82M$. In the last quarter, BlackRock decreased its holdings by -181K shares, a -0.91% change.

Who is NeoGenomics’s biggest shareholder by percentage of total assets invested?

First light asset management is NeoGenomics’s biggest shareholder by percentage of total assets invested, with 6.47% of its assets in 9.73M NeoGenomics shares, valued at 72.2M$.

Who is the top mutual fund holder of NeoGenomics shares?

First Trust NYSE Arca Biotech ETF is the top mutual fund holder of NeoGenomics shares, with 7.51% of its total shares outstanding invested in 9.78M NeoGenomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools